The Vanguard Group 13D/13G Filings for Forma Therapeutics Holdings, Inc. (FMTX)

The Vanguard Group 13D and 13G filings for Forma Therapeutics Holdings, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-10
08:11 am
Purchase
2021-12-3113GForma Therapeutics Holdings, Inc.
FMTX
The Vanguard Group2,860,653
6.030%
2,860,653increase
(New Position)
Filing